Literature DB >> 1334041

Internalization of monoclonal antibodies selected for immunotoxin activity against small-cell lung cancer.

J K Weltman1, C L Melucci, J Chen, A E Davidson.   

Abstract

Two hybridomas producing MOABs with anti-SCLC activity were selected for immunotoxin activity by an indirect screen and were twice cloned. Binding activity of the MOABs to SCLC cells was demonstrated by immunoperoxidase activity, which could be blocked by streptavidin. The MOABs mediated the internalization of a biotinylated Fab' anti-mouse Ig marker at 37 degrees C. Internalization of the biotinylated marker by the SCLC target cells resulted in protection of the marker from streptavidin-blocking. These results show that MOABs selected for immunotoxin activity against SCLC can mediate internalization of an antibody fragment with a mass about 50% greater than that of the toxin. MOABs selected for immunotoxin activity may be useful for delivering agents other than toxins to the inside of SCLC cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334041     DOI: 10.1089/hyb.1992.11.547

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  1 in total

1.  Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.

Authors:  Debra Ehrlich; Bo Wang; Wei Lu; Peter Dowling; Ruirong Yuan
Journal:  J Hematol Oncol       Date:  2014-12-19       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.